Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cullinan

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Geriatric Psychiatry|February 7, 2013
The effects of dependence and function on costs of care for Alzheimer's disease and mild cognitive impairment in IrelandP Gillespie, E O'Shea, J Cullinan, et al.
Bjpsych Bulletin|April 12, 2023
Spiritually significant hallucinations: a patient-centred approach to tackle epistemic injusticeRachel J Cullinan, Angela Woods, Joanna M P Barber, et al.
ANZ Journal of Surgery|March 29, 2003
Recognition and management of biliary complications after laparoscopic cholecystectomyBenjamin N J Thomson, Mark J Cullinan, Simon W Banting, et al.
Cancer Treatment Reviews|December 1, 1987
Structural modifications of the vinca alkaloidsI S Johnson, G J Cullinan, G B Boder, et al.
Acta Psychiatrica Scandinavica|June 30, 2022
Documentation and diagnosis of delirium in Parkinson's diseaseRachel J Cullinan, Sarah J Richardson, Alison J Yarnall, et al.
Journal of Cardiovascular Pharmacology|October 12, 2000
Raloxifene and estrogen inhibit neointimal thickening after balloon injury in the carotid artery of male and ovariectomized female ratsR F Kauffman, J S Bean, K J Fahey, et al.
Journal of Medicinal Chemistry|April 1, 1987
Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivativesW S Marshall, T Goodson, G J Cullinan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1984
Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) releaseJ H Fleisch, K D Haisch, S M Spaethe, et al.
Journal of Medicinal Chemistry|March 1, 1989
New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activityB C Laguzza, C L Nichols, S L Briggs, et al.
The Journal of Clinical Investigation|January 1, 1994
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized ratsL J Black, M Sato, E R Rowley, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Geriatric Psychiatry|February 7, 2013
The effects of dependence and function on costs of care for Alzheimer's disease and mild cognitive impairment in IrelandP Gillespie, E O'Shea, J Cullinan, et al.
Bjpsych Bulletin|April 12, 2023
Spiritually significant hallucinations: a patient-centred approach to tackle epistemic injusticeRachel J Cullinan, Angela Woods, Joanna M P Barber, et al.
ANZ Journal of Surgery|March 29, 2003
Recognition and management of biliary complications after laparoscopic cholecystectomyBenjamin N J Thomson, Mark J Cullinan, Simon W Banting, et al.
Cancer Treatment Reviews|December 1, 1987
Structural modifications of the vinca alkaloidsI S Johnson, G J Cullinan, G B Boder, et al.
Acta Psychiatrica Scandinavica|June 30, 2022
Documentation and diagnosis of delirium in Parkinson's diseaseRachel J Cullinan, Sarah J Richardson, Alison J Yarnall, et al.
Journal of Cardiovascular Pharmacology|October 12, 2000
Raloxifene and estrogen inhibit neointimal thickening after balloon injury in the carotid artery of male and ovariectomized female ratsR F Kauffman, J S Bean, K J Fahey, et al.
Journal of Medicinal Chemistry|April 1, 1987
Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivativesW S Marshall, T Goodson, G J Cullinan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1984
Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) releaseJ H Fleisch, K D Haisch, S M Spaethe, et al.
Journal of Medicinal Chemistry|March 1, 1989
New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activityB C Laguzza, C L Nichols, S L Briggs, et al.
The Journal of Clinical Investigation|January 1, 1994
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized ratsL J Black, M Sato, E R Rowley, et al.
Pageof 8